1999
DOI: 10.1118/1.598697
|View full text |Cite
|
Sign up to set email alerts
|

Anatomy‐based three‐dimensional dose optimization in brachytherapy using multiobjective genetic algorithms

Abstract: In conventional dose optimization algorithms, in brachytherapy, multiple objectives are expressed in terms of an aggregating function which combines individual objective values into a single utility value, making the problem single objective, prior to optimization. A multiobjective genetic algorithm (MOGA) was developed for dose optimization based on an a posteriori approach, leaving the decision-making process to a planner and offering a representative trade-off surface of the various objectives. The MOGA pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
59
0

Year Published

2001
2001
2021
2021

Publication Types

Select...
4
3
2

Relationship

1
8

Authors

Journals

citations
Cited by 62 publications
(59 citation statements)
references
References 14 publications
0
59
0
Order By: Relevance
“…The most common ones are simulated annealing algorithms [14][15][16] and genetic algorithms. [17][18][19] Gradient algorithms also have been applied. 20 In general, gradient algorithms give reproducible solutions but may be trapped in local minima far from the global minimum.…”
Section: Introductionmentioning
confidence: 99%
“…The most common ones are simulated annealing algorithms [14][15][16] and genetic algorithms. [17][18][19] Gradient algorithms also have been applied. 20 In general, gradient algorithms give reproducible solutions but may be trapped in local minima far from the global minimum.…”
Section: Introductionmentioning
confidence: 99%
“…There has been studies in automating each of these steps. For example, there has been extensive effort in developing planning systems for computing optimal dose distributions for both PPI-and HDR-BT [17,18,19,20,21,22]. These dose planning systems allow physicians to compute dose distributions without directly adjusting the dwell times to meet treatment objectives.…”
Section: Background and Related Workmentioning
confidence: 99%
“…Yu, 1997;Lahanas et al, 1999;Yu et al, 2000;Lessard et al, 2006). This is because the aim of brachytherapy is to treat the tumor without affecting healthy tissue but, naturally, increasing the dose in the tumor also increases the unwanted dose in surrounding healthy tissue.…”
Section: Introductionmentioning
confidence: 99%